Tuesday, 5 November 2019

Telehealth Market Dynamics, Forecast, Analysis and Supply Demand 2019

Rising worldwide Prevalence of Chronic Diseases Coupled with the Rise in Geriatric Population are Expected to Boost the Growth of the Telehealth Market Research Report - Global Forecast till 2024 at a CAGR of 22.74% During the Forecast Period of 2019 to 2024:
Market Scenario:
Telehealth is the provision of medical help in remote locations through the use of telecommunication technologies such as video conferencing. Although a relatively new concept, telehealth solutions garnered many accolades in recent years since it bridges the gap amid patients and healthcare professionals.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/900
The global telehealth market has grown considerably against the backdrop of an alarming surge in the incidence rate of chronic diseases and mounting healthcare costs. Patients prefer telehealth solutions for the management of diseases such as cancer, diabetes, and respiratory disorders which require constant monitoring. Penetration of smartphones and smart devices has also increased the acceptance rate of telehealth solutions. The rise in geriatric population who are in greater need of medical attention also foster the growth of the global telehealth market. Improvement of telecom infrastructure, especially in developing countries has facilitated the deployment of telehealth solutions. Among other factors which can augment the market growth include a shortage of healthcare professionals. In addition, unwillingness to serve in remote locations paired with the outbreak of natural disasters also supports market growth. Government endeavors to incorporate telehealth solutions as a part of routine operational flow is likely to trigger the market growth. On the other hand, the growth of the global telehealth market might be undermined by underdeveloped infrastructure and unavailability of technical know-how in developing countries. Interoperability and legal issues associated with ensuring patient confidentiality are other major bottlenecks.
Key players
Leading players profiled in the telehealth market  include InTouch Technologies, Inc. (US), GlobalMedia Group, LLC (US), AMD Global Telemedicine, Inc. (US), Cerner Corporation (US), Siemens Healthcare Private Limited (US), Care Innovations, LLC. (US), McKesson Corporation (US), Koninklijke Philips N.V. (the Netherlands), Medtronic (Ireland), and General Electric Company (UK).
March 2019- Berkley County School District is all set to roll out telehealth that is school-based shortly. By joining hands with the school district and MUSC, their goal is in eliminating barriers and offering care to students who lack transportation for visiting the physician’s office.
Market Segmentation
Market Research Future report offers an all-inclusive segmental analysis of the telehealth market on the basis of components, end user, and type.

Based on component, it has been segmented into software, hardware, and others. Hardware segment is further segmented into medical devices, monitors and others. Monitors are again segmented into ECG monitors, blood pressure monitors, blood glucose monitors and others.
Based on end user, the telehealth market has been segmented into pharmaceutical companies, hospitals and clinics, and others.
Based on type, it is segmented into on-premise, web-based, and cloud-based.
Regional Analysis
Based on region, the telehealth market covers growth opportunities and latest trends across the Americas, Asia Pacific, Europe, and the Middle East & Africa. Of these, the Americas will have an upper hand in the telehealth market. Massive patient pool suffering from chronic diseases and a considerably high number of the aged populace is creating a favorable setting for the growth of the market. The deployment of telehealth solutions is highly feasible due to the robust healthcare system and technology advancement in the region. Improvement and amendment of telehealth laws aimed at providing improved access to care have been a plus for the growth of the market. Europe follows the Americas closely and is expected to showcase substantial growth in the coming years. The developed countries in the region are demonstrating greater interest in the deployment of telehealth services which is enhancing the growth of the market. Germany is likely to contribute significantly to the growth of the market. The telehealth market in the APAC region is expected to expand with rapid momentum and capture the highest CAGR over the forecast period. The existence of emerging countries such as China and India which are adopting telehealth services at a torrid pace is favoring the growth of the market. On the other hand, the Middle East and Africa accounts for the smallest share of the market. Sluggish adoption of telehealth solutions due to poor economic conditions, low healthcare expenditure and lack of awareness are restricting the growth of the market. The Middle East holds the bulk share of the MEA market.
Browse the market data and information spread across 164 pages with 273 data tables and 19 figures of the report segmented by“by Component, by Mode of Delivery, by Application (Radiology, Cardiology, Primary Care, Neurophysiology and others), by End User and by Region” in-depth alongside table of content (TOC) at: https://www.marketresearchfuture.com/reports/telehealth-market-900
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:

Monday, 4 November 2019

Hypersensitivity Pneumonitis Market to Observe Significant Growth by 2019

Market Research Future (MRFR) has announced a new release on the global Hypersensitivity Pneumonitis market. The report takes into account the global Hypersensitivity Pneumonitis market’s historical growth trajectory and major growth drivers and restraints in order to come up with a reliable projection for the market’s likely growth trajectory over the forecast period from 2018 to 2023.
Market Synopsis of Global Hypersensitivity Pneumonitis Market
There are various players operating in the global Hypersensitivity Pneumonitis market, some of the major players are Novartis (Switzerland), Abbott (U.S.), AstraZeneca (U.K), Abbott (US) Eli Lilly (U.S.), Bayer Cropscience Ltd. (U.S.).,  Sunpharma (India), Merck & Co. (U.S.), Pfizer (U.S.), Svizera Healthcare (India), F. Hoffman La Roche AG (Germany), Sanofi (France), and Novo Nordisk (Denmark). and others
Hypersensitivity pneumonitis is a complex syndrome caused due to exposure to a variety of organic particles. Hypersensitivity pneumonitis is divided into three types, acute hypersensitivity pneumonitis, subacute hypersensitivity pneumonitis, and chronic hypersensitivity pneumonitis which is based on the based on the duration of the illness. According to the American Academy of Allergy, Asthma & Immunology (2013), 10%-30% of the global population suffers from allergic rhinitis. Increasing prevalence of patients suffering from hypersensitivity pneumonitis, and increasing pollution have boosted the growth of the market. Additionally, According to the American Academy of Allergy, Asthma & Immunology, in 2013, globally, sensitization rates to one or more common allergens among school children is approximately 40%-50% and in 2012, 10.6% children were diagnosed with respiratory allergies. Moreover, increasing prevalence of respiratory diseases, increasing healthcare expenditure, and strong government support for research & development have also contributed to the growth of the market. Rising geriatric population also supports the growth of the market. However, lack of long term treatment and awareness about the diseases may lead to slow the growth of the market.
Global Hypersensitivity Pneumonitis Market   - Regional Analysis
America commands the largest market for hypersensitivity pneumonitis majorly due to increasing patient population. According to the Asthma and Allergy Foundation of America, in 2015, nasal allergies affect about 50 million people in the United States of which 30 % are adults and 40 % are children. Additionally, peanut is the most common allergen followed by milk and shellfish. In 2015, 4.2 million children in the US have food allergies. Changing environment condition, and increasing government support have supported the market growth.
On regional basis, the Americas Hypersensitivity pneumonitis market is segmented into two major regions, North America and South America. North America commands the largest market in this region. North America is further segmented into the US and Canada. High healthcare spending, increasing prevalence of the respiratory diseases and government encouragement will boost the market in North America. However, South America shows the fastest growth for the American market owing to the presence of huge opportunities for the development of the market.
The Americas hypersensitivity pneumonitis market is segmented on the basis of types, therapy, and end users. On the basis of types, the market is segmented into acute hypersensitivity pneumonitis, subacute hypersensitivity pneumonitis, and chronic hypersensitivity pneumonitis. On the basis of therapy, the market is segmented into diagnosis, and treatment. Diagnosis is further segmented into chest lung function tests, X-ray, lung biopsy, and others. Treatment is further classified into pharmacological and non-pharmacological. Pharmacological is further segmented into corticosteroid therapy, immunosuppressive therapy and others. On the basis of end users, the market is segmented into hospital, clinics, and others.
Europe is the second largest market for hypersensitivity pneumonitis, which is followed by Asia Pacific. Availability of funds for research, changing environment conditions and government support for research & development will drive the market.
Asia Pacific is expecting fastest growth for the market due to the presence of a huge patient population, presence of huge opportunity in the market, and huge geriatric population. India and China are the major contributors for the market. According to the WHO in 2013, approximately 20-30% of Indian population suffers from at least one allergic disease and 8.7% of the total china’s population suffers from allergic rhinitis. Increasing prevalence of diseases have boosted the growth of the Asia Pacific market.
On the other hand, the Middle East & Africa holds the least share in the global hypersensitivity pneumonitis market due limited development in the healthcare sector and poor economy in Africa region. Majority of the market of this region is held by the Middle East due to huge healthcare spending.
Browse Premium Research Report with Tables and Figures @ https://www.marketresearchfuture.com/reports/hypersensitivity-pneumonitis-market-4649
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Ear Infection Treatment Market 2019 Share, Trend, Segmentation and Forecast to 2023

Market Scenario
An ear infection occurs due to invasion by bacteria or virus causing pain, inflammation and fluid build-up in the ear. Most ear infections are acute but chronic ear infections can cause permanent damage to the middle and inner ear. Eustachian tubes, small tubes running from ear to the back of the throat, get swollen or blocked causing fluid to build up in the middle ear.
The causes of Eustachian tube blockage include allergies, colds, sinus infections, excess mucus, etc. Other factors that increase the risk of developing an ear infection are altitude changes, climate changes, recent illness, exposure to cigarette smoke, etc. Common symptoms of ear infections include pain, persistent feeling of pressure inside the ear, pus like ear drainage, hearing loss etc. Serious complications include hearing loss, speech or language delay in children, infection of the mastoid bone in the skull (mastoiditis), bacterial infection of the membranes covering the brain and spinal cord (meningitis), ruptured eardrum and other.
The market drivers for global ear infection treatment market are rise in risk factors, increasing awareness regarding the severity of untreated ear infection, development of healthcare, technological development in diagnostic devices and surgery segment especially the advancements in minimally invasive surgery etc. The market restraints are the complications of surgery, high cost of treatment, emergence of bacterial resistance, etc.
The Global Ear Infection Treatment Market is expected to reach USD 22.3 Billion by 2023, and the market is projected to grow at a CAGR of Approx 6.6 % during the forecast period 2017-2023.
Key Players
American Diagnostic Corporation, Pfizer plc., Heine USA Ltd., , Welch Allyn, TorquePharma, Medtronic, Intersect ENT, Inc., Olympus Corporation, Grace Medical, American Diagnostic Corporation and others.
Segmentation
The global ear infection treatment market has been segmented on the basis of type, pathogen diagnosis, treatment, and end user.
Based on the type, the market has been segmented as outer ear, middle ear, inner ear.
Based on the pathogen, the market has been segmented as bacteria, virus and others.
Based on the diagnosis, the market has been segmented as hearing test, microbial test, otoscopy and tympanometry, Computerized Tomography (CT), other.
Based on the treatment, the market has been segmented as surgery, drugs, and others.
Based on the end user, the market has been segmented as hospitals & clinics, academic and research, and others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Friday, 1 November 2019

Top trends in Biological Computers Market by 2019

Biological computers are systems developed form basic components such as software, hardware, input and output. DNA and RNA are the basis of biological systems used as software for constructing the biological systems.
Prevalence of cancer such as lung cancer, mouth cancer, and bone cancer is on the rise across the globe, especially in the developing countries. The market is driven by the increasing prevalence of respiratory diseases in rural areas for developing countries. In addition, increasing research and development activities in the field of oncology, and technological advancements made to identify the causes and risk factors for chronic diseases have added fuel to the global biological computers market growth. Rising awareness about gene chip and other biological systems that can be used for cell transformation with the help of information technology also drives the market growth.
Biological computers, also known as DNA computers, are microcomputers designed for their use in the field of medicine. This implantable device can be used for various functions such as monitoring the activities of the body or inducing therapeutic effects. Hardware, software, input, and output are the four major components of a biological computer. These components are made of DNA, RNA and proteins. Biological computers are able to perform mathematical calculations that enable the researcher to construct a system of biosensors. This system of biosensors can detect or target specific types of cells such as cancer cells in the patient’s body.
As per the report of the Centers for Disease Control and Prevention (CDC), in 2014, over 14.1 million of new cancer cases were registered worldwide.
The global biological computers market is expected to grow at a CAGR of 7.1% during the forecast period 2017-2023.
Key Players   
  • Microsoft (U.S.)
  • IBM (U.S.)
  • Thermofisher Scientific (U.S.)
  • Illumina, Inc. (U.S.)
  • IndieBio (U.S.)
  • Emulate Inc. (U.S.)
Key Players manufactruing DNA or gene chips
  • Sequenom Inc.
  • Merck KGaA (U.S.)
  • Macrogen Corp (Republic of Korea)
  • Bioneer Corporation (Republic of Korea)
  • Biometrix Technology Inc (U.S.)
  • Wafergen Biosystems Inc. (U.S.)
  • Eurofins Genomics India Pvt Ltd. (India)
Segmentation                                                                                                                                            
The global biological computers market is segmented on the basis of component, application, and end user.
On the basis of the component, market is segmented into hardware, software, input, and output.
On the basis of the application, the market is segmented into oncology, molecular genetics, nanobiotechnology, and others.
On the basis of the end user, the market is segmented into pharmaceutical & biotechnology companies, research centers, healthcare it companies, hospital & clinics, and others.
Regional Analysis   
The Americas hold the first position in the biological computers market owing to the rising prevalence of cancer in the U.S., and increasing demand for new cancer diagnostic and treatment services. In the Americas, North America is the largest market owing to the presence of key players in the healthcare IT industry.
Europe is the second largest market for biological computers. In Europe, there is an increasing demand for healthcare IT solutions and extensive research and development activities is taking place by clinical research and academic institutes for cancer treatment. According to Cancer Research UK, in 2014, 356,860 new cases of cancer were reported, including 579 cases of bone cancer.  
The market in Asia Pacific is expected to grow at the fastest pace and is driven by the high prevalence of chronic disease such as cancer, obesity, diabetes and other. India, China, and Japan are major contributors to the growth of the market. This growth is attributed to an increasing demand for technologically advanced medical devices and accessories such as gene chips for research activities. Availability of highly qualified medical professionals dedicated to research in biological systems is also a contributing factor. The various other factors affecting the growth of the market in Asia Pacific are rising geriatric population, demand for advanced therapies, government initiatives, and increasing public awareness about various diseases and the available treatments.
Additionally, healthcare spending in Asia Pacific expanded in 2016 due to an extension of state healthcare programs, and the increasing affluence of the population. Organization for Economic Co-operation and Development (ECOD) stated that growth in India will remain high at 7.3% in 2017.
The Middle East & Africa also show a steady rise in the market owing to low technological penetration and increasing awareness about cancer treatment. In the Middle East & Africa, Middle East captures the largest market share for biological medicines owing to the availability of better healthcare infrastructure and wide scope for research.
Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/biological-computers-market-5067
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Heart Tumor Market 2019 Share, Trend, Segmentation and Forecast to 2023

Heart Tumor Market Scenario
According to the surgery and autopsy reports, primary cardiac tumors are rare with an incidence rate of about 0.3%-0.7%. Malignant primary cardiac sarcomas are usually located in the right atrium of the heart and are most commonly angiosarcomas. The malignant primary cardiac tumors are often diagnosed in young patientswho have a poor prognosis and survival rate of only 10% According to the WHO, the prevalence of melanoma skin cancers has been increasing from the past few decades. Furthermore, 132,000 melanoma skin cancers cases are reported each year across the globe.
The Global Heart Tumor Market is expected to grow at a CAGR of approximately 7.1% during the forecast period.
Cardiac tumors is a rare disease that aredifficult to diagnose. They are divided on the basis of type into primary and secondary tumors. The prevalance of the secondary tumors is higher than the primary tumors. Majority of the primary cardiac tumors are benign in origin. The high incidences of metastatic tumors  is attributed to various types of  cancers such as lung, breast, renal cancer, lymphomas and melanomas. Clinical manifestations of these tumors generally based on  the size and location of the tumors and spread to the adjacent tissues rather than the type of the tumor itself.  Echocardiography is the major tool used for diagnosis of the tumors. Other imaging modalities include cardiac MRI, cardiac CT, and 3D echocardiography, which may offer some additional information with histological examination.
A small percentage of cardiac tumor cases are hereditary, the tumors can also be associated with another health condition, such as LAMB Syndrome, Carney Syndrome or NAME Syndrome. However, most often, the tumor develops without being associated with any health condition or presence of a family history. They result from cell overgrowth but mostly cardiac tumors results from metastatic condition, where cells from other cancerous organ such as lung and breast, soft-tissues and metastasizes to the heart.
Heart Tumor Market Key Players
Some of key the players in the Global heart tumor market are Tomtec Imaging Systems GmBh, Koninklijke Philips N.V., Siemens Healthineers, Circle Cardiovascular Imaging Inc., Toshiba Corporation, Shimadzu Corporation, CardioComm Solutions Inc., Integer Holdings Corporation, Pie Medical Imaging, HeartSciences, 3mensio Medical Imaging, and eMedica, S.L.

Heart Tumor Market Segmentation
The heart tumor is segmented on the basis of type, diagnosis, treatment.
On the basis of the type, the market is segmented into primary tumors and secondary tumors. The primary tumors are divided into benign and malignant. The benign tumors is further categorized into myxoma, papillary heart tumors, fibromas, rhabdomyomas, angioma, and lipomas. The malignant tumors are divided into rhabdomyosarcoma, mesenchymomas, neurosarcoma, fusiform cell tumors, malignant heart hemangioma, and lymphosarcoma. The secondary tumor is categorized into metastatic and contiguity. The metastatic secondary tumors are divided into hematogenic and lymphatic and the contiguity is sub categorized into mediastinal tumors, lung tumors and oesophageal, or cardia tumor.
On the basis of the diagnosis, the market is classified into echocardiogram, Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI), radionuclide imaging, Position Emission Tomography (PET) Scan, myocardial biopsy, cardiac catherization, and electrophysiology test.
On the basis of the treatment, the market is classified into surgery, chemotherapy, radiation therapy. Furthermore, the surgery is further categorized into open heart surgery, minimal invasive surgery, and heart transplant surgery 
International Heart Tumor Market Regional Analysis
The global heart tumor market consists of four major regions: the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas dominate the market owing to the rising awareness among people and increasing healthcare expenditure. The type of tumors also aids in selection of treatment procedure. For instance, in patient with heart cancers, the results of cardiac imaging could be used to see if the the tumor is spread to the adjacent tissues, which can be further used to remove the portion by performing excision surgery or pursuing treatment with medications.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Diabetic Neuropathy Treatment Market 2019 Share, Trend, Segmentation and Forecast to 2023

Market Scenario:
The Global Diabetic Neuropathy Treatment Market is expected to cross USD 5.80 Billion by 2025 at a CAGR of 5.1%.
Market Synopsis
The number of diabetic neuropathy cases is increasing globally, fueling market growth. Diabetic neuropathy treatment is the second-highest contributor to global disability and an estimated 30% to 40% of people across the globe live with diabetic neuropathy.
Diabetic neuropathy is most common in low- and middle-income countries, and this disorder requires lifelong care to manage.
Market Influencer
The rising prevalence of diabetic disorders and increasing reimbursement offered to patients by health insurance providers.
Market Drivers
  • Growing global geriatric population.
  • Change in lifestyle habits leading to bad posture, which is increasing the prevalence of diabetic neuropathy disorder.
  • Increasing research and development of new drugs to treat diabetic neuropathy disorder.
  • Rising prevalence of diabetic neuropathy. For example, the prevalence of diabetic neuropathy in the fiscal year 2000 to 2030 will reach up to 366 million people in the US.
  • Rising awareness of advanced treatments for diabetic neuropathy.
  • Launch of a new medication to manage the symptoms of chronic diabetic neuropathy.
Market Restraints
  • High treatment costs.
  • Availability of alternative therapies such as traditional medicine and physiotherapy.
  • Need for specialized equipment to diagnose and treat diabetic neuropathy.
Segmentation
By Disorder
  • Peripheral Neuropathy: The largest segment of the market, peripheral neuropathy afflicts almost 1% of the entire global population and is three times as likely to afflict women than men.
  • Autonomic Neuropathy: This disorder generally afflicts elderly people. As of 2018, about 23 million people in the US had autonomic neuropathy and over a quarter of those afflicted could not perform daily activities.
  • Proximal Neuropathy: It is a rare type of nerve damage that occurs in hip, buttock, or thigh. It typically affects one side of the body and rarely spreads to the other side of the body. About 50% of patients suffering from diabetes have proximal neuropathy.
  • Focal Neuropathy: This focal neuropathy disorder afflicts roughly 3 out of every ten individuals who have diabetes with over 100 million people affected globally.
By Treatment
  • Drugs: The fastest-growing segment of the market, drugs are most widely used for the treatment of diabetic neuropathy. A rise in the number of FDA approvals for drugs to treat diabetic neuropathy is a key factor for the growth of the segment.
  • Transcutaneous Electrical Nerve Stimulation (TENS): The largest segment, TENS is the preferred treatment for many diabetic neuropathies as they reduce inflammation and suppress immune system activity.
  • Others: The other segment includes physiotherapy and electroacupuncture and various other treatment options for diabetic neuropathy.
By End-User
  • Hospitals and Clinics: The largest segment, hospitals, and clinics are usually the primary points for diagnosis, treatment, and rehabilitation of individuals afflicted with diabetic neuropathy. Growing awareness and increasing efficiency of diabetic neuropathy treatment are projected to drive the growth of this segment during the forecast period.
  • Retail Pharmacy: A small segment. This center provides immediate pain relief and rudimentary drugs for diabetic neuropathy.
  • Online Pharmacy: Various drugs are used for the treatment of diabetic neuropathy which can be easily available in online pharmacy.
  • Others: This segment includes home care and senior citizen centers.
By Region
  • Americas: The largest regional market. The prevalence of diabetic neuropathy is high in the Americas. The region also has a well-established healthcare industry. Out of the entire population, around 72.2% people in the US were suffering from diabetic neuropathy in 2017.
  • Europe: An increasing geriatric population is leading to a rise in the number of diabetic neuropathy disorder cases.
  • Asia-Pacific: The fastest-growing regional market. Asia-Pacific is seeing a surge in the number of people afflicted with diabetic neuropathy due to bad posture brought on by lifestyle changes, aging, and genetic predisposition. Diabetic neuropathy is an increasing problem in Asia. Approximately 4000 patients were diagnosed with diabetic neuropathy in Korea in 2017, whereas in Japan, around 298 people were diagnosed with diabetic neuropathy in 2017.
  • Middle East & Africa: The smallest market due to limited healthcare infrastructure and a very young population.Top of Form
Bottom of Form
Browse Complete 111 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/diabetic-neuropathy-treatment-market-8359
Key Players
  • Abbott Laboratories (US)
  • Hoffmann-La Roche Ltd (Switzerland)
  • Eli Lilly and Company (US)
  • Johnson & Johnson (US)
  • GlaxoSmithKline Plc (UK)
  • Lupin Limited (India)
  • Glenmark Pharmaceuticals Limited (India)
  • Depomed, Inc. (US)
  • Astellas Pharma Inc (Japan)
  • Pfizer Inc (US)
  • MEDA Pharma GmBH & Co. KG (Germany)
  • Others

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Tuesday, 29 October 2019

Mortuary Refrigerator Market 2019 Global Industry Key Players, Share, Trend, Segmentation and Forecast to 2023

Mortuary Refrigerator Market Scenario:
Mortuary refrigerators are used to keep dead bodies as a solution to maintain hygiene requirements in hospitals. The key factors contributing for the market growth are growing number of cancer patient and cancer-related research, increasing organ transplant, and growing demands for automation in mortuary procedures. Also, the increasing geriatric population, is contributing to drive the market. According to the United Census Bureau, the global-female-geriatric population is estimated to reach 4,139 million by 2030 from 3,601 million in 2015. However, the minimal awareness about mortuary equipment and fluctuating prices of raw materials and substituting products for mortuary refrigerators hinders the market growth.
There are several companies involved in manufacturing of mortuary refrigerators with advanced features and ease to use. However, the cost of mortuary refrigerators compare to other mortuary related products and presence of alternative products in the market are hindering the market growth.
Some of the key players in the global mortuary refrigerators market are LEEC (UK), Hygeco (Saint-Ouen, (UK)), Paragon scare Ltd. (London), Thalheimer Kühlung (UK), Barber Medical (UK), CEABIS (Italy), EIHF Isofroid (UK), EVERmed (Italy), and Fiocchetti and Funeralia (UK) and others.
The global mortuary refrigerator market is expected to register a CAGR of 4.3% during the forecast period of 2018 to 2023.
Mortuary refrigerators are the largely used equipment in the whole mortuary equipment market. These refrigerators have available with several features such as temperature adjustable knob, multiple chambers. Mortuary refrigerators are available in both positive and negative temperature facility. The positive temperature refrigerator slows down the degradation process of dead bodies for a period of time, and the negative temperature mortuary refrigerators are used to storage the body by freezing it and prevent degradation for longer duration. The increase in technology and rising demand for automation in mortuary procedures is one of the reasons for the larger share of the market.
Segmentation
The global mortuary refrigerator market is segmented on the basis of product type, application, application, end user, and region.
On the basis of product type, the market is segmented into positive temperature, negative temperature refrigerators.
By application, the market is categorised into corpses storage and forensic investigation. On the basis of end-user, the global mortuary refrigerator market is categorised into forensic labs, research and academics, funeral homes, hospitals and clinics, and others.
Regional Market Summary
The Americas dominates the global market for mortuary refrigerator owing to the increase in cancer and cancer-related research activities, increasing number of geriatric populations with health-related problems and presence of major market players within the region boosts the market growth. According to the Administration for Community Living in 2016, the number of older women within the region was estimated to be 26.7 million. Furthermore, the presence of developed economies and regulations by various authorities in healthcare sector within the region boosts the market growth.
In 2017, it was estimated that Europe stood second in the global mortuary refrigerator market. The increase in demand for mortuary refrigerator by forensic labs and hospitals to store the dead bodies for investigation increases the market growth. These equipment’s are also, used to store the entire body donated for medical research purpose, which are used in medical colleges to teach human anatomy.
Asia Pacific was the fastest growing region for the global mortuary refrigerator market in 2017. Factors such as increasing awareness about the advanced and innovative mortuary refrigerator, growing regulations and policies by various authorities regarding the hygiene in hospital drives the market growth.
On the other hand, the Middle East and Africa holds a least share in the global mortuary refrigerator market due to the lack of awareness about the advanced mortuary procedures and mortuary refrigerator hinders the market growth in this region.
Browse Complete 110 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/mortuary-refrigerator-market-7437
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Subscribe to: Posts (Atom)